Publication
Enhancing Patient Centricity in Clinical Trials Through Connected Devices and Digitalised Data Collection
Latest article published on International Clinical Trials, outlining with the rising use of wearables and connected devices in clinical trials, what are the key considerations for sponsors, sites, and patients when engaging with these technologies?
Jun 09, 2023

Industry stakeholders have worked to enhance patient centricity in R&D in recent years in hopes of improving patient engagement and ensuring they have a stronger voice in their clinical care. This noticeable shift toward patient centricity also intends to help sponsors address long-standing challenges in successfully designing and executing clinical trials.

Decentralized Clinical Trials (DCT) solutions are being validated by accommodating patients' needs to improve their trial experiences and not compromise their safety and data quality, while at the same time benefiting sponsors by reducing trial delays and related costs (1).

Taking a closer look at connected devices and wearable technologies, including smart phones and watches, biosensors, and varying monitors (e.g., blood pressure, electrocardiogram, diabetes, etc.), finds that these specific DCT solutions are increasing in availability and use within trials.

Currently, there are nearly 670 studies either in recruitment or active stages incorporating wearables to examine these devices for use in various therapeutic areas, patient populations, and capacities (2). These devices collect an extensive breadth of data which allows sponsors and study teams to dive deeper into patient behavioral trends and capture richer insights near real-time that inform smarter decisions.

This article was part of International Clinical Trials February 2023 edition: https://www.calameo.com/read/006113385cea01a9a4adc?page=30

Related solutions

Contact Us